Quick Order Cart

Cat. No. ARG39347

DNAJC7 Knockout Raji Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Bone

  • Disease:

    Burkitt lymphoma

The DNAJC7 Knockout Raji Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout population derived from human Raji B lymphocyte cells, designed for loss-of-function studies of the DNAJC7 co-chaperone. DNAJC7 cooperates with Hsp70/Hsp90 to regulate client protein folding and directly modulates RIPK1-IKK-NF-??B signaling, linking proteostasis to stress responses. This model is especially relevant for investigating chaperone-mediated NF-??B regulation in Burkitt??s lymphoma, studying protein aggregation in neurodegeneration, and identifying therapeutic targets. Key interacting factors include Hsp70, Hsp90, RIPK1, and IKBKG, and typical assays involve Western blotting, co-immunoprecipitation, and NF-??B reporter analysis.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    Raji

    Cell Type

    B cell line

    Sex of Donor

    Male

    Age

    11 years

    Derived From Site

    In situ; Maxilla

    Gene Name

    DNAJC7

    Gene Identifier

    NCBI Gene ID 7266

    Morphology

    Lymphoblast-like

    Growth Mode

    Suspension

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    RPMI 1640

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The CRISPR/Cas9-edited DNAJC7 Knockout Raji Polyclonal Cells represent a loss-of-function model generated by CRISPR/Cas9-mediated disruption of the DNAJC7 gene in the human Raji B lymphocyte cell line. This polyclonal knockout cell population provides a heterogeneous pool of gene-edited cells, enabling the study of DNAJC7-dependent functions without clonal selection artifacts. The knockout product format is suitable for pooled screening approaches and population-level biochemical analyses.

Raji cells are a widely used suspension cell line derived from a Burkitt’s lymphoma patient, characterized by their Epstein-Barr virus (EBV)-positive status and B lymphocyte lineage. They retain features of mature B cells, including the capacity for immunoglobulin secretion and roles in immune surveillance. Their rapid proliferation and well-characterized signal transduction networks make them an excellent model for dissecting oncogenic and stress-responsive pathways in lymphoid malignancies.

DNAJC7 encodes a co-chaperone that cooperates with Hsp70 and Hsp90 to facilitate the folding, stabilization, and degradation of client proteins, including steroid hormone receptors such as the glucocorticoid receptor and androgen receptor. DNAJC7 directly interacts with RIPK1 and IKBKG (NEMO), and it regulates NF-??B signaling by modulating the IKK complex. Its activity is induced by upstream signals including heat shock factor 1 (HSF1), cellular stress (e.g., heat shock, oxidative stress), and inflammatory cytokines like TNF-??. Downstream, DNAJC7 modulates RIPK1 kinase activity, IKK complex function (IKBKB and IKBKG), and consequently NF-??B transcriptional responses mediated by RELA and NFKBIA. It also chaperones diverse Hsp70/Hsp90 clients, linking proteostasis to inflammatory and apoptotic pathways.

In the Raji B-cell context, loss of DNAJC7 is expected to disturb chaperone networks and impair NF-??B activation in response to stress and cytokines. Since Burkitt’s lymphoma cells rely on constitutive NF-??B activity for survival and proliferation, this knockout model may uncouple proteotoxic stress responses from pro-survival signaling. The resulting phenotype can reveal vulnerabilities in proteostasis and stress signaling that are relevant to B-cell malignancies, as well as neurodegenerative diseases where DNAJC7 mutations are linked to amyotrophic lateral sclerosis and frontotemporal dementia.

This polyclonal knockout model is suitable for investigating chaperone-mediated control of NF-??B in B-cell lymphomas, studying protein aggregation and unfolded protein response pathways, and performing functional analyses of Hsp70/Hsp90 co-chaperones. Typical experimental readouts include Western blotting for DNAJC7, Hsp70, and Hsp90; co-immunoprecipitation of chaperone complexes; NF-??B reporter and DNA-binding assays; annexin V-based apoptosis detection; RT-qPCR for NF-??B target genes; and heat shock protein induction profiling. The model is also a valuable tool for drug target discovery in lymphoma and ALS. For additional technical details, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)